Old Web
English
Sign In
Acemap
>
authorDetail
>
Mahdi Hashemi
Mahdi Hashemi
AstraZeneca
Medicine
Placebo
Dosing
Adverse effect
Internal medicine
3
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
2021
British Journal of Clinical Pharmacology
Muhammad Waqas Sadiq
Sara Asimus
Maria G. Belvisi
Wayne Brailsford
Rebecca Fransson
Rainard Fuhr
Anette Hagberg
Mahdi Hashemi
Tina Jellesmark Jensen
Julia Jonsson
Christina Keen
Thomas Körnicke
Cecilia Kristensson
Jukka Mäenpää
Sofia Necander
Szilard Nemes
Joanne Betts
Show All
Source
Cite
Save
Citations (0)
A Phase 2a, Double-Blind, Placebo-Controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
2020
American Journal of Respiratory and Critical Care Medicine
Ioannis Psallidas
Vibeke Backer
Piotr Kuna
Robert Palmér
Sofia Necander
Malin Aurell
Katarina Korsback
Ziad Taib
Mahdi Hashemi
Per Gustafson
Sara Asimus
Stephen Delaney
Katerina Pardali
Fanyi Jiang
Joachim Almquist
Sam Jackson
Robert L. Coffman
David Keeling
Tariq Sethi
Show All
Source
Cite
Save
Citations (5)
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials
2019
Tove Hegelund Myrbäck
Susanne Prothon
Karl Edman
Jacob Leander
Mahdi Hashemi
Matthew Dearman
Goran Edenro
Petter Svanberg
Eva-Marie Andersson
Joachim Almquist
Carina Ämmälä
Ramon Hendrickx
Ziad Taib
Kicki A Johansson
Anders Berggren
Christina Keen
Ulf G. Eriksson
Rainard Fuhr
Björn Carlsson
Show All
Source
Cite
Save
Citations (6)
1